Latest publications

Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling.

Bray G. et al, (2026), J Med Econ, 29, 2091 - 2106

Social and Health Conditions That Drive the Need and Demand for, Use of and Expenditure on Social Care in the UK: A Systematic Review

Scott AM. et al, (2026), Cochrane Evidence Synthesis and Methods, 4

Determinants and associations of health-related quality of life with mortality in acute and chronic heart failure: findings from the ESC HF III Registry

Walli-Attaei M. et al, (2026), European Journal of Heart Failure

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

STOKES L. et al, (2026), Transfusion

A Cost Is a Cost Is a Cost - Or Is It? Consistently Accounting for Costs in Health Technology Assessment

McElwee F. et al, (2026)

A randomised controlled feasibility study of brief cognitive therapy for the treatment of PANic Disorder in Adolescents (PANDA).

Waite P. et al, (2026), Behav Cogn Psychother, 1 - 23

Measuring Health Inequalities and Disparities in Influenza and COVID-19 Vaccination Status across 28 European Countries

Cole S. et al, (2026)

Implementation of a learning health system for the management of non-communicable diseases in Thailand: a realist evaluation protocol.

Marszalek M. et al, (2026), BMJ Open, 16

EQ-5D vision bolt-on in macular degeneration: associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy.

Zhu X. et al, (2026), Health Qual Life Outcomes, 24

Impact of preventive treatment on healthcare use: a modelling study of statin treatment.

Zhou J. et al, (2026), Value Health

Valuation of Child Health-Related Quality of Life by Child Age and Problem Duration Using a Novel Method.

Jumamyradov M. et al, (2026), Value Health

The impact of restricting price promotions on foods high in fat, sugar, and salt on purchasing behaviours: A randomised controlled trial in a simulated online supermarket.

Jia R. et al, (2026), Public Health Nutr, 1 - 23

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.

Brewer G. et al, (2026), Trials, 27

Addition of rituximab to first-line treatment of Burkitt lymphoma in children and young adults in Tanzania: a cost-utility analysis

MORRELL L. et al, (2026), Journal of Clinical Oncology Global Oncology

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial.

Roukas C. et al, (2026), BMJ Open Gastroenterol, 13